HPLC- MS Method for Analysis of Naloxone and Buprenorphine Sublingual Film  8mg/2 mg  on Primesep 100  Column

https://sielc.com/hplc-method-for-analysis-of-naloxone-buprenorphine-ms
⬇ PDF Download

Chromatogram

Description

Naloxone and buprenorphine are both medications with distinct pharmacological profiles, but they are often used together in the treatment of opioid dependence.

Naloxone is a drug with the chemical formula C 19 H 21 NO 4 . It is primarily used to reverse opioid overdoses. When administered during an overdose, naloxone can quickly restore normal respiration by binding to opioid receptors and preventing opioids from activating them.

Buprenorphine is a drug with the chemical formula C 29 H 41 NO 4 . It is used for pain management and as a treatment for opioid dependence. As a partial agonist, it can activate opioid receptors but not to the same extent as full agonists like morphine. This property allows buprenorphine to reduce cravings and withdrawal symptoms in individuals with opioid dependence without producing the same intense “high” or dangerous side effects as other opioids.

Combination in Treatment : Buprenorphine and naloxone are combined in products like Suboxone. The purpose of this combination is to provide the therapeutic benefits of buprenorphine for opioid dependence while discouraging misuse. If someone tries to dissolve and inject the combination, naloxone will block the effects of buprenorphine and potentially induce withdrawal, thereby acting as a deterrent to this route of misuse. However, when taken sublingually as prescribed, the naloxone component has minimal bioavailability and thus minimal effect, allowing the buprenorphine component to exert its therapeutic action.

Naloxone , Buprenorphine can be retained, separated and analyzed on a Primesep 100 mixed-mode stationary phase column using an isocratic analytical method with a simple mobile phase of water, Acetonitrile (MeCN), and a ammonium format as a buffer. This analysis method can be detected using UV at 269 nm, an Evaporative Light Scattering Detector (ELSD), or any other evaporative detection method (CAD, ESI-MS)

Method Parameters

Mobile PhaseMeCN – 80%,
BufferAmmonium Formate pH 3.0-20 mM
Flow Rate0.2 ml/min
DetectionUV, 283 nm, SIM 328 +, SIM 468 +
Spray Voltage:1.5 kV
Nebulizing gas:1.5 L/min
Drying gas:15 L/min
DL temp:250 ˚C
Heat Block:400 ˚C
Class of CompoundsDrug, Opioid antagonist,
Analyzing CompoundsNaloxone,Buprenorphine

HPLC Column Used

Primesep 100, 2.1 x 100 mm, 5 µm, 100 A, dual ended